Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2S2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM192A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MANF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKTIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAI3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YWHAZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFDN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3BGRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6834 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6866 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on